U.S. FDA Drug Approvals for Breast Cancer: A Decade in Review.

MLA

Arora, Shaily, et al. “U.S. FDA Drug Approvals for Breast Cancer: A Decade in Review.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 28, no. 6, Mar. 2022, pp. 1072–86. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-21-2600.

APA

Arora, S., Narayan, P., Osgood, C. L., Wedam, S., Prowell, T. M., Gao, J. J., Shah, M., Krol, D., Wahby, S., Royce, M., Ghosh, S., Philip, R., Ison, G., Berman, T., Brus, C., Bloomquist, E. W., Fiero, M. H., Tang, S., Pazdur, R., … Beaver, J. A. (2022). U.S. FDA Drug Approvals for Breast Cancer: A Decade in Review. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 28(6), 1072–1086. https://doi.org/10.1158/1078-0432.CCR-21-2600

Chicago

Arora, Shaily, Preeti Narayan, Christy L Osgood, Suparna Wedam, Tatiana M Prowell, Jennifer J Gao, Mirat Shah, et al. 2022. “U.S. FDA Drug Approvals for Breast Cancer: A Decade in Review.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 28 (6): 1072–86. doi:10.1158/1078-0432.CCR-21-2600.